Brainsway (BWAY) announces its Gold Sponsorship of the Clinical TMS Society’s 2025 Annual Meeting, taking place June 12-14 in San Diego, CA. BrainsWay’s participation will spotlight its Deep Transcranial Magnetic Stimulatio technology, including live demonstrations and groundbreaking new research that continues to set Deep TMS apart. BrainsWay will host a sponsored morning session titled, “Accelerating Relief: Multicenter RCT Results from a Novel H1 Coil Accelerated Deep TMS Depression Protocol” which will be presented by Colleen Hanlon, PhD, BrainsWay’s Vice President of Clinical & Medical Affairs. The session will unveil compelling preliminary results from a recent multicenter randomized non-inferiority trial which compared BrainsWay’s standard Deep TMS depression protocol to a novel, accelerated protocol, both using the Company’s proprietary H1 Coil – without any reliance on neuronavigation equipment.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BWAY:
- BrainsWay Invests $5 Million in Stella MSO to Boost Mental Health Access
- Brainsway announces $5M minority-stake investment in Stella MSO
- BrainsWay’s Earnings Call Highlights Robust Growth and Strategic Advancements
- BrainsWay Reports Record Sales and Profit Growth
- BrainsWay Achieves Record Sales and Growth in Q1 2025